Eli Lilly Long-Term Investments 2010-2024 | LLY

Eli Lilly long-term investments for the quarter ending June 30, 2024 were $2.878B, a 4.83% increase year-over-year.

  • Eli Lilly long-term investments for 2023 were $3.052B, a 5.18% increase from 2022.
  • Eli Lilly long-term investments for 2022 were $2.902B, a 9.67% decline from 2021.
  • Eli Lilly long-term investments for 2021 were $3.213B, a 8.29% increase from 2020.

Eli Lilly Long-Term Investments 2010-2024 | LLY

  • Eli Lilly long-term investments for 2023 were $3.052B, a 5.18% increase from 2022.
  • Eli Lilly long-term investments for 2022 were $2.902B, a 9.67% decline from 2021.
  • Eli Lilly long-term investments for 2021 were $3.213B, a 8.29% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B